Print

P53 Mutation Hinders Cancer Treatment Response, National Cancer Centre Singapore Study  
1/28/2013 7:32:10 AM

Scientists from the National Cancer Centre Singapore (NCCS) have discovered the workings of the gene that has been hindering treatment response in cancer patients. This discovery was made after 5 years of studying the mutant form of the p53 gene, the major tumor suppressor in humans, which is generally found mutated in over 50% of all type of human cancers.